ceftazidime
Selected indexed studies
- Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview. (Antimicrob Agents Chemother, 2022) [PMID:35980232]
- Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections. (Drugs, 2018) [PMID:29671219]
- Ceftazidime review. (Drug Intell Clin Pharm, 1985) [PMID:3896712]
_Worker-drafted node — pending editorial review._
Connections
ceftazidime is a side effect of
Sources
- Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview. (2022) pubmed
- Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections. (2018) pubmed
- Ceftazidime review. (1985) pubmed
- Ceftazidime dosing in obese patients: is it time for more? (2022) pubmed
- Ceftazidime for respiratory infections. (2012) pubmed
- Ceftazidime-related neurotoxicity in a patient with renal impairment: a case report and literature review. (2024) pubmed
- Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination. (2013) pubmed
- The primary pharmacology of ceftazidime/avibactam: in vivo translational biology and pharmacokinetics/pharmacodynamics (PK/PD). (2022) pubmed
- Pharmacotherapy Review of Ceftazidime-Avibactam. (2017) pubmed
- Ceftazidime-related nonconvulsive status epilepticus. (1994) pubmed